These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27327448)

  • 1. Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis.
    Toth-Manikowski SM; Francis JM; Gautam A; Gordon CE
    Clin Transplant; 2016 Sep; 30(9):1090-6. PubMed ID: 27327448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis.
    Yang Y; Qiu S; Deng L; Tang X; Li X; Wei Q; Fu P
    BMC Nephrol; 2018 Oct; 19(1):269. PubMed ID: 30340537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
    Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
    Wang J; Yao M; Xu JH; Shu B; Wang YJ; Cui XJ
    Osteoporos Int; 2016 May; 27(5):1683-90. PubMed ID: 26733377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for preventing bone disease in kidney transplant recipients.
    Palmer SC; McGregor DO; Strippoli GF
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005015. PubMed ID: 17636784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.
    Kan SL; Ning GZ; Chen LX; Zhou Y; Sun JC; Feng SQ
    Medicine (Baltimore); 2016 Feb; 95(5):e2679. PubMed ID: 26844505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bisphosphonates on bone mineral density in liver transplant patients: a meta-analysis and systematic review of randomized controlled trials.
    Kasturi KS; Chennareddygari S; Mummadi RR
    Transpl Int; 2010 Feb; 23(2):200-7. PubMed ID: 19793074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation.
    Mainra R; Elder GJ
    Clin J Am Soc Nephrol; 2010 Jan; 5(1):117-24. PubMed ID: 19965527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bisphosphonates on bone mineral density and fracture prevention in gastric cancer patients after gastrectomy.
    Lim JS; Jin SH; Kim SB; Lee JI
    J Clin Gastroenterol; 2012 Sep; 46(8):669-74. PubMed ID: 22504799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for preventing bone disease in kidney transplant recipients.
    Palmer S; McGregor DO; Strippoli GF
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005015. PubMed ID: 15846740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
    Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
    Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bisphosphonates on bone loss in the first year after renal transplantation--a meta-analysis of randomized controlled trials.
    Mitterbauer C; Schwarz C; Haas M; Oberbauer R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2275-81. PubMed ID: 16574684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.
    McKee H; Ioannidis G; Lau A; Treleaven D; Gangji A; Ribic C; Wong-Pack M; Papaioannou A; Adachi JD
    Osteoporos Int; 2020 May; 31(5):973-980. PubMed ID: 31900542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials.
    Yang Y; Qiu S; Tang X; Li XR; Deng LH; Wei Q; Fu P
    Chin Med J (Engl); 2018 Apr; 131(7):818-828. PubMed ID: 29578126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.
    Sebba AI
    Clin Ther; 2008 Mar; 30(3):443-52. PubMed ID: 18405784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Bisphosphonate Therapy for Osteogenesis Imperfecta: A Systematic Review and Meta-Analysis of Six Randomized Placebo-Controlled Trials.
    Ying ZM; Hu B; Yan SG
    Orthop Surg; 2020 Aug; 12(4):1293-1303. PubMed ID: 32589343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates and bone fractures in long-term kidney transplant recipients.
    Conley E; Muth B; Samaniego M; Lotfi M; Voss B; Armbrust M; Pirsch J; Djamali A
    Transplantation; 2008 Jul; 86(2):231-7. PubMed ID: 18645484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis.
    Thongprayoon C; Acharya P; Aeddula NR; Torres-Ortiz A; Bathini T; Sharma K; Ungprasert P; Watthanasuntorn K; Suarez MLG; Salim SA; Kaewput W; Chenbhanich J; Mao MA; Cheungpasitporn W
    Arch Osteoporos; 2019 Mar; 14(1):35. PubMed ID: 30852679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate therapy after liver transplant improves bone mineral density and reduces fracture rates: an updated systematic review and meta-analysis.
    Ho OTW; Ng WCA; Ow ZGW; Ho YJ; Lim WH; Yong JN; Wang RS; Wong KL; Ng CH; Muthiah MD; Teo CM
    Transpl Int; 2021 Aug; 34(8):1386-1396. PubMed ID: 33884669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials.
    Palmer SC; Strippoli GF; McGregor DO
    Am J Kidney Dis; 2005 Apr; 45(4):638-49. PubMed ID: 15806466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.